Literature DB >> 8569441

Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.

C W Jung1, P Jacobs.   

Abstract

The bulk physiochemical properties of the active ingredients in three AMI colloidal, superparamagnetic iron oxide (SPIO), MR contrast agents are described. Ferrous content and X-Ray diffraction (XRD) of the colloids are consistent with nonstoichiometric magnetite phases in all three active ingredients. No separate maghemite (gamma-Fe2O3) phases were detected by XRD. XRD line-broadening determinations of representative samples of ferumoxides (dextran coated), Ferumoxtran (dextran covered), and ferumoxsil (siloxane coated) yielded mean crystal diameters (volume weighted distribution) of 4.8-5.6, 5.8-6.2, and 7.9-8.8 nm, respectively. Transmission electron microscopy (TEM) showed that the crystal sizes were lognormally distributed with respective mean crystal diameters (number weighted distribution) of 4.3-4.8, 4.3-4.9, and 8.0-9.5 nm, respectively. Consistent with their small crystal sizes, the three SPIO colloids are superparamagnetic with no remanence after saturation at high applied fields (< 1 T), and showed characteristic relaxed Mössbauer spectra. The Mössbauer spectra of ferumoxides and Ferumoxtran were consistent with the presence of superparamagnetic relaxation above a blocking temperature of approximately 60 K. Due to the larger crystal sizes of ferumoxsil, its Mössbauer spectra showed the presence of rapid collective magnetic excitations on the Mössbauer time scale (approximately 1-10 ns). All three colloids showed high MR relaxivities. TEM of the SPIO colloids showed that ferumoxides and ferumoxsil are composed of aggregates of nonstoichiometric magnetite crystals, while Ferumoxtran consists of single crystals of nonstoichiometric magnetite. Dynamic light scattering (PCS) measurements showed that Ferumoxtran particles have average hydrodynamic diameters of approximately 21 nm (number weighted distribution) or 30 nm (volume weighted distribution). The data indicate that Ferumoxtran crystals are coated with an 8-12 nm layer of dextran T-10. Ferumoxides aggregates have average particle sizes of approximately 35 nm (number average distribution; TEM and PCS), or approximately 50 nm (volume weighted distribution; PCS). Mean sizes of ferumoxsil aggregates are approximately 300 nm (intensity weighted distribution). A discussion of the various particle size distributions is presented.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569441     DOI: 10.1016/0730-725x(95)00024-b

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  109 in total

Review 1.  Imaging the lymphatic system: possibilities and clinical applications.

Authors:  Olivier Clément; Alain Luciani
Journal:  Eur Radiol       Date:  2004-03-09       Impact factor: 5.315

Review 2.  Inorganic nanoparticle-based contrast agents for molecular imaging.

Authors:  Eun Chul Cho; Charles Glaus; Jingyi Chen; Michael J Welch; Younan Xia
Journal:  Trends Mol Med       Date:  2010-11-10       Impact factor: 11.951

Review 3.  Recent Developments in Magnetic Diagnostic Systems.

Authors:  Hakho Lee; Tae-Hyun Shin; Jinwoo Cheon; Ralph Weissleder
Journal:  Chem Rev       Date:  2015-08-10       Impact factor: 60.622

4.  Combined off-resonance imaging and T2 relaxation in the rotating frame for positive contrast MR imaging of infection in a murine burn model.

Authors:  Ovidiu C Andronesi; Dionyssios Mintzopoulos; Valeria Righi; Nikolaos Psychogios; Meenu Kesarwani; Jianxin He; Shingo Yasuhara; George Dai; Laurence G Rahme; Aria A Tzika
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

5.  Non-invasive analysis of myoblast transplants in rodent cardiac muscle.

Authors:  Kevin S Cahill; Sean Germain; Barry J Byrne; Glenn A Walter
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

6.  Dextran-Coated Iron Oxide Nanoparticles as Biomimetic Catalysts for Localized and pH-Activated Biofilm Disruption.

Authors:  Pratap C Naha; Yuan Liu; Geelsu Hwang; Yue Huang; Sarah Gubara; Venkata Jonnakuti; Aurea Simon-Soro; Dongyeop Kim; Lizeng Gao; Hyun Koo; David P Cormode
Journal:  ACS Nano       Date:  2019-01-22       Impact factor: 15.881

7.  Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors.

Authors:  Trevor P Wade; Piotr Kozlowski
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

8.  Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs.

Authors:  James C Kaczmarek; Asha K Patel; Kevin J Kauffman; Owen S Fenton; Matthew J Webber; Michael W Heartlein; Frank DeRosa; Daniel G Anderson
Journal:  Angew Chem Int Ed Engl       Date:  2016-09-30       Impact factor: 15.336

Review 9.  Nanoparticles for imaging and treating brain cancer.

Authors:  Joseph D Meyers; Tennyson Doane; Clemens Burda; James P Basilion
Journal:  Nanomedicine (Lond)       Date:  2013-01       Impact factor: 5.307

10.  Conquering the dark side: colloidal iron oxide nanoparticles.

Authors:  Angana Senpan; Shelton D Caruthers; Ilsu Rhee; Nicholas A Mauro; Dipanjan Pan; Grace Hu; Michael J Scott; Ralph W Fuhrhop; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Journal:  ACS Nano       Date:  2009-12-22       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.